GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.

Elijah Heacock, 16, of Glasgow, Kentucky, was the target of a cruel scam. Before he took his own life, the teen exchanged more than 150 text messages with the person threatening him. Swift, who ...